Business Context and Reporting Period
This Form 8-K Current Report was filed by LIFECORE BIOMEDICAL, INC. on August 12, 2025. The filing addresses a change in the Company's independent registered public accounting firm for the transition period beginning May 26, 2025, and ending December 31, 2025.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity figures. The document focuses exclusively on auditor engagement and internal control disclosures.
Material Changes
- Engagement of New Auditor: The Audit Committee appointed KPMG LLP as the independent registered public accounting firm for the transition period ending December 31, 2025.
- Dismissal of Prior Auditor: The Audit Committee dismissed BDO USA, P.C. on August 12, 2025.
- Audit Opinions: BDO's audit reports for fiscal years ended May 26, 2024, and May 25, 2025, did not contain adverse opinions or disclaimers. However, BDO reported that the Company did not maintain effective internal control over financial reporting due to material weaknesses.
Outlook, Risks, and Contingencies
Material Weaknesses in Internal Controls: The filing details persistent material weaknesses in internal control over financial reporting as of May 25, 2025, affecting the following COSO components:
- Control Environment: Insufficient personnel to support internal control objectives.
- Risk Assessment: Inadequate identification of risks related to recent disposition activities and business model changes.
- Information and Communication: Deficiencies in validating the completeness and accuracy of information used in control activities.
- Monitoring: Failure to design and implement monitoring activities responsive to control deficiencies.
- Control Activities: Ineffective controls resulting from the above weaknesses.
Specific Accounting Areas Impacted: The material weaknesses relate to the accounting for non-standard transactions, inventory valuation, capitalization of interest on assets under construction, recording of development revenue and related costs, presentation of operating costs for continuing and discontinued operations, and the write-off of receivables from the former Curation Foods business.
Consultations: The Company confirmed no disagreements with BDO regarding accounting principles or auditing scope. No reportable events occurred other than those previously disclosed in the 2025 Form 10-K.
Investor Verification Checklist
- Verify the status of remediation efforts for the material weaknesses in internal controls identified as of May 25, 2025.
- Review the transition plan between BDO USA, P.C. and KPMG LLP for the period ending December 31, 2025.
- Examine the specific financial impact of the accounting errors previously identified (e.g., inventory valuation, Curation Foods receivables) in the most recent 10-K.
- Confirm whether the material weaknesses have been resolved prior to the issuance of the next audit report by KPMG.